---
title: "Goldman Sachs trims Fresenius Medical Care voting rights to 4.64% from 5.04%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300317867.md"
description: "Goldman Sachs reduced its voting rights stake in Fresenius Medical Care from 5.04% to 4.64%. This change, which crossed the relevant threshold on September 21, 2026, also saw holdings tied to shares drop to 1.01% and voting rights through instruments ease to 3.63%. The update was published via EQS News on September 28, 2026."
datetime: "2026-09-28T14:09:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300317867.md)
  - [en](https://longbridge.com/en/news/300317867.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300317867.md)
generator: "portal-rs"
---

# Goldman Sachs trims Fresenius Medical Care voting rights to 4.64% from 5.04%

-   Goldman Sachs cut its total voting rights stake in Fresenius Medical Care to 4.64% from 5.04%. \* Holdings tied to shares slipped to 1.01% from 1.19%. \* Voting rights through instruments eased to 3.63% from 3.85%. \* Threshold was crossed on Sep. 21, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR\_2406308\_en) on September 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [FMS.US](https://longbridge.com/en/quote/FMS.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [GS-A.US](https://longbridge.com/en/quote/GS-A.US.md)
- [GS-C.US](https://longbridge.com/en/quote/GS-C.US.md)
- [GS-D.US](https://longbridge.com/en/quote/GS-D.US.md)
- [FME.DE](https://longbridge.com/en/quote/FME.DE.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [BUZZ-FMC slips after new US kidney-care strategy](https://longbridge.com/en/news/302530164.md)
- [Goldman Sachs Stock Price Forecast: Q3 Earnings Push Stock Past $900, Can It Reclaim All-Time High of $1,154 This Year?](https://longbridge.com/en/news/302177515.md)
- [How Investors May Respond To Goldman Sachs Stock Tokenization Push](https://longbridge.com/en/news/302356411.md)
- [Inflexion sells majority stake in Celnor to Goldman Sachs Alternatives](https://longbridge.com/en/news/302901106.md)
- [Fresenius Medical Care (FME) Launches FDA‑Cleared multiFiltratePRO CKRT System in U.S.](https://longbridge.com/en/news/302616871.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**